Search Results
Jun 22, 2026, 12:14 ET Piramal Pharma Solutions hebt starke Leistung bei mehr als 200 Kundenaudits hervor
zuverlässiger globaler CDMO-Partner weiter aus.MUMBAI, Indien, 22. Juni 2026 /PRNewswire/ -- Piramal Pharma Solutions („PPS"), ein weltweit führendes Auftragsentwicklungs- und Produktionsunternehmen (CDMO) und Teil der Piramal
More news about: Piramal Pharma Solutions
Jun 22, 2026, 12:11 ET Piramal Pharma Solutions met en avant ses excellents résultats lors de plus de 200 audits clients
culture de la qualité, au développement des ressources humaines et à la transformation numérique, Piramal continue de renforcer sa position de partenaire CDMO mondial de confiance.MUMBAI, Inde, 22 juin 2026 /PRNewswire/
More news about: Piramal Pharma Solutions
Jun 22, 2026, 10:30 ET Fill Finish Manufacturing Market worth $30.37 billion by 2031 | MarketsandMarkets™
Europe accounted for the largest share of the global market, driven by its strong pharmaceutical and biopharmaceutical manufacturing base, extensive CDMO network, and widespread adoption of advanced aseptic processing technologies. The region benefits from stringent regulatory standards, significant investments
More news about: MarketsandMarkets
Jun 22, 2026, 09:00 ET U.S. Biomedical Innovation Leadership at Risk: New Data Show China Rapidly Closing Gap as Clinical Trials and Manufacturing Migrate Abroad
6China leads on manufacturing scale, CDMO capacity, and raw materials Talent
More news about: Cure.
Jun 22, 2026, 07:14 ET Piramal Pharma Solutions destaca su sólido rendimiento en más de 200 auditorías de clientes
por contrato (CDMO).MUMBAI, India, 22 de junio de 2026 /PRNewswire/ -- Piramal Pharma Solutions ("PPS"), una de las principales organizaciones globales de desarrollo y fabricación por contrato (CDMO) y parte de Piramal
More news about: Piramal Pharma Solutions
Jun 22, 2026, 07:00 ET Taiwan Biotech Delegation Heads to BIO 2026 to Advance Global Partnerships and Innovation
the Taiwanese delegation will feature advancements spanning drug development, precision medicine, Contract Development and Manufacturing Organization (CDMO) services, biomanufacturing and digital health at the Taiwan Pavilion (Booth #2621).Guided by the theme "Taiwan, Your Best Partner
More news about: BPIPO
Jun 22, 2026, 05:15 ET ChemT Biotechnology Raises US$5 Million in 18 months to bring AI to Biomanufacturing
of ChemT Biotechnology. "Within roughly a year and half of launch, we've built commercial partnerships with more than 40 pharmaceutical, biotech, and CDMO companies across the globe. The future of biomanufacturing will not be won by automation alone -- it will require intelligence."The financing
More news about: ChemT Biotechnology
Jun 22, 2026, 04:57 ET Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits
as a reliable global CDMO partner.MUMBAI, India, June 22, 2026 /PRNewswire/ -- Piramal Pharma Solutions ("PPS"), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma
More news about: Piramal Pharma Solutions
Jun 22, 2026, 04:46 ET Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits
as a reliable global CDMO partner.MUMBAI, India, June 22, 2026 /PRNewswire/ -- Piramal Pharma Solutions ("PPS"), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma
More news about: Piramal Pharma Solutions
Jun 21, 2026, 20:00 ET LOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and Obtains Approval for Use
strategy linking Songdo Bio Campus with Syracuse Bio Campus in New York, the United States, LOTTE Biologics is now positioned to provide integrated CDMO services that connect early-stage clinical production with large-scale commercial manufacturing. Under this model, the Syracuse Bio Campus will support
More news about: LOTTE Biologics
Jun 18, 2026, 08:00 ET Matica Biotechnology Launches Integrated Korea IIT Platform Solution to Accelerate Global Advanced Therapy Development
2026 /PRNewswire/ --Matica Biotechnology, Inc. (Matica Bio), a leading viral vector contract development and manufacturing organization (CDMO) specializing in advanced therapies, today announced the launch of the Accelerated Matica Korea IIT Integrated Platform Solution, a collaborative framework
More news about: Matica Biotechnology, Inc.
Jun 18, 2026, 08:00 ET Minaris Enhances GMP Cell Banking Suites at Philadelphia Facility
PHILADELPHIA, June 18, 2026 /PRNewswire/ -- Minaris, a global cell and gene therapy (CGT) CDMO and multimodal biosafety testing organization, today announced the enhancement of its dedicated GMP cell banking suites at its Philadelphia facility,
More news about: Minaris Advanced Therapies, LLC
Jun 18, 2026, 07:07 ET Six Taipei Biotechs Head to BIO 2026 in San Diego, With Precision Medicine, Drug Delivery, and Bioprocess Innovation in Focus
Pharmaceutical, Leadgene Biosolutions, FEBICO (Far East Bio-Tec Co., Ltd.), PharmiGENE, TAHO Pharma, and Instant NanoBiosensors — span therapeutics, diagnostics, CDMO services, biosensing, and bioprocess instrumentation. Taken together, they reflect a sector that has moved well beyond contract services and into areas
More news about: GeneOnline
Jun 18, 2026, 00:57 ET WuXi Biologics' Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Market
please visit: www.wuxibiologics.com.*The winner of the "2026 Biologics CDMO of the Year" (Large CDMOs) (Life Science Connect / Outsourced Pharma)*The winner of the "2026 Best Contract Development & Manufacturing Organization
More news about: WuXi Biologics
Jun 16, 2026, 08:15 ET Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower
Inc. — "Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program" (June 8, 2026; Q1 2027 510(k) plan, CDMO transfer, Ten-Minute Tissue™):
More news about: American News Group
Jun 16, 2026, 08:00 ET Matica Biotechnology and Cirsium Biosciences Announce Adoption of Matica Open Access Platform to Accelerate Flexible AAV Manufacturing
fromtraditional CDMO constraintsCOLLEGE STATION, Texas and SAN DIEGO, June 16, 2026 /PRNewswire/ -- **Matica Biotechnology, Inc. (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing
More news about: Matica Biotechnology, Inc.
Jun 15, 2026, 08:00 ET CCRM, OmniaBio and Avectas Partner to Improve Cell Therapy Manufacturing
infrastructure. In 2022, CCRM established OmniaBio Inc., a commercial-stage CDMO for manufacturing cell and gene therapies. Visit us at ccrm.ca.About OmniaBioOmniaBio Inc. is a global cell and gene therapy CDMO and a subsidiary of CCRM, with over a decade of expertise in regenerative
More news about: The Centre for Commercialization of Regenerative Medicine
Jun 11, 2026, 14:17 ET Meet the Ph.D. Dietitian Helping Wellness Brands Solve Their Toughest Formulation Challenges
Innovative Labs, a premier contract development and manufacturing organization (CDMO) for the health and wellness industry, the answer starts with who is leading the work.
More news about: Innovative Labs
Jun 11, 2026, 12:37 ET /C O R R E C T I O N -- Dispensary of Hope/
commitment," Chastain adds.About The Ritedose CorporationRitedose is the largest sterile contract development manufacturing organization (CDMO) in the US specializing in sterile Blow Fill Seal (BFS) technology that ensures sterile, consistent, and safe unit dose delivery. The company's process
More news about: Dispensary of Hope
Jun 11, 2026, 07:45 ET Valion Bio (NASDAQ: VBIO) Confirms U.S. House Armed Services Committee Initiative to Address Urgent Need for Radiation /Nuclear Countermeasures
oncology supportive care. Valion Bio's wholly owned subsidiary, Velocity Bioworks, is a full-service contract development and manufacturing organization (CDMO) that offers biomanufacturing services to third-party biotech companies. Valion Bio also leverages Velocity Bioworks' manufacturing capabilities to
More news about: Valion Bio, Inc.
Jun 11, 2026, 03:00 ET Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
Japan. Through ongoing partnerships with more than 10 global pharmaceutical companies, Samil Pharmaceuticals Co., Ltd. is expanding its business into CMO/CDMO services in the ophthalmology sector and has built a state-of-the-art facility in Ho Chi Minh City, Vietnam, which has already obtained WHO GMP certification.
More news about: Formosa Pharmaceuticals Inc.,
Jun 10, 2026, 10:15 ET Digital Medical Partnerships Market Size to Reach USD 3.76 Billion by 2031 Driven by Healthcare Digital Transformation and Connected Care Growth | Valuates Reports
Medical Device OEM/ODM/CDMO Market was valued at USD 115434 Million in the year 2024 and is projected to reach a revised size of USD 191760 Million by 2031, growing at a CAGR
More news about: Valuates Reports
Jun 10, 2026, 07:55 ET Scinai Reports First Quarter 2026 Financial Results and Provides Corporate Update Highlighting Expansion of CDMO Platform and Advancement of Strategic Growth Initiatives
Completed the acquisition of Recipharm Israel, expanding the Company's CDMO platform through the addition of a second manufacturing site in Yavne, Israel, and establishing a strategic commercial collaboration with global CDMO leader Recipharm AB.Advanced multiple non-dilutive funding initiatives
More news about: Scinai Immunotherapeutics Ltd.
Jun 09, 2026, 08:00 ET Matica Biotechnology announces engagement by University Health Network (UHN) to supply cGMP Manufacturing of IL-10 Adenoviral Therapy for Lung Transplantation
9, 2026 /PRNewswire/ -- Matica Biotechnology, Inc. ("Matica Bio"), a leading viral vector contract development and manufacturing organization (CDMO) specializing in advanced therapies, is pleased to announce its engagement with University Health Network (UHN). The agreement includes cGMP
More news about: Matica Biotechnology, Inc.
Jun 08, 2026, 16:17 ET CAREstream America introduces new era of science-backed innovation to deliver a new standard of quality to the US aesthetic market
capabilities in cell therapy, spanning from treatment development to Cell and Gene Therapy Contract Development and Manufacturing Organization (CGT CDMO) services. The group also operates Asia-Pacific's largest medical network, with 96 medical institutions across 7 countries, including South Korea, the
More news about: CAREstream America